FDA Brief

Company record

Rising Pharma Holding, Inc.

0 FDA warning letters since 2023 and 2 recalls in the last 12 months.

Get an email the day FDA posts anything new about Rising Pharma Holding, Inc..

Recalls

ReportedClassFirmProduct and reason
Jul 29 Class II Rising Pharma Holding, Inc.
Drug
Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Laboratories, Inc., Brockton, MA. NDC 64980-504-…
Presence of Precipitate: medication was crystallizing and particles floating in the bottle
Mar 11 Class II Rising Pharma Holding, Inc.
Drug
Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Country of origin: Taiwan, NDC 16571-816-51.
Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing